medigraphic.com
SPANISH

Revista Médica Electrónica

ISSN 1684-1824 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 6

<< Back Next >>

Rev Méd Electrón 2013; 35 (6)

Cervical congenital neuroblastome in a newborn: presentation of a case

Medina DR, Moreno KS, Robainas FI, Medina RRE, Fariñas GM, Dorta RM
Full text How to cite this article

Language: Spanish
References: 11
Page: 622-627
PDF size: 460.05 Kb.


Key words:

congenital neuroblastoma, malignant tumor, nervous tissue, newborn, solid cervical mass, aerodigestive compromise.

ABSTRACT

Cervical congenital neuroblastomes are very rare. This form of infantile cancer forms in the nervous tissue and generally it uses to appear more frequently in the suprarenal glands. Although they may appear prenatally, they are more frequent in the first year after birth. They are aggressive tumors with a high mortality. In almost all the cases (50/60 % of them), when a neuroblastome is detected, it is already disseminated to other parts of the body. We present the case of a newborn who shows a history of respiratory and digestive tracts compromise associated to a solid cervical mass and XII cranial par paralysis during the first 24 hours after birth.


REFERENCES

  1. Carachi R, Grosfeld J, Azmy A (Eds): Tumors. 2da ed. Berlin, Heidelberg: Springer Verlag; 2008.

  2. López Ibor B. Tumores de la cresta neural. En: Tratado de Oncología Pediátrica. Sierrasesúmaga L, Antillón Klussmann F (Eds): Madrid: Pearson Prentice Hall; 2006. p. 553-70.

  3. Bagatell R, Rumcheva P, London WB, Cohn SL, Look AT, Brodeur GM, et al. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy. J Clin Oncology. 2005; 23 (34): 8819-27. Citado en PubMed; PMID: 16314642.

  4. Neuroblastoma. Enciclopedia médica en español; 2008.

  5. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet [Internet].2077 [citado 29 Ene 2009];369 (9579): 2106–20. Disponible en: http://www.thelancet.com/journals/lancet/article/PIIS0140- 6736%2807%2960983-0/fulltext

  6. Tsubono Y, Hisamichi S. A Halt to Neuroblastoma Screening in Japan. N Engl J Med. 2004;350(19):2010-1.Citado en PubMed; PMID 15128908.

  7. Macmillan Cancer Support. In neuroblastoma, how can MIBG be both a test and a treatment? Types of Children's Cancers. EE UU;2008.

  8. Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM,et al. The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol. 2009 Jan 10; 27(2):289-97. Citado en PubMed; PMID:19047291.

  9. Sano H, Bonadio J, Gerbing R, London W, Matthy K, Lukens J, et al. International neuroblastoma 6. pathology classification adds independent prognostic information beyond the prognostic contribution of age. Europ J Cancer. 2006;42 (8):1113- 19.Citado en PubMed; PMID: 16624549.

  10. Behrman RE, Kliegman RM, Jenson HB. Nelson. Tratado de Pediatría. España: Elsevier; 2004.

  11. Shimada H, Chatten J, Newton WA Jr, Sachs N, Hamoudi AB, Chiba T, et al. Histopathologic prognostic factors in neuroblastic tumors: 5. definition of subtypes of ganglioneuroblastoma and aged-linked classification of neuroblastoma. J Natl Cancer Inst. 1984;73(2):405-16. Citado en PubMed; PMID:6589432.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Méd Electrón. 2013;35